Discovery

For nearly four decades, JMPS has been designing novel drug targets for clients and developing synthetic routes. We are uniquely positioned to deliver cutting-edge collaborative medicinal chemistry services with a proven track record.

We employ the latest technologies to provide rapid access to new chemical entities, helping to facilitate lead identification. Our unique combination of catalytic expertise and separations capabilities facilitate your lead qualification process. Targets that are known or suspected to have toxic properties are easily handled in our various facilities.

Collaborative medicinal chemistry programs provide extensive value-added service and intellectual property (IP) to our drug discovery clients, from small biotech to large pharmaceutical companies. Since we are a service-only business, all IP developed in collaboration with our client’s programs belongs to you.

In support of discovery research, JMPS offers full organic analytical capabilities, including NMR, HPLC, chiral HPLC, GC, GC-MS, LC-MS, FTIR, Ion chromatography (IC), capillary electrophoresis (CE), Karl Fischer and a variety of wet chemical techniques.

Our ion-trap LC-MS systems are open access and employ fast LC so that our discovery scientists can obtain real time analysis during route scouting and process development. These MS systems are also capable of MSn for determining more extensive structural information.

Aligned with these services, we offer a seamless internal tech transfer to facilitate a rapid scale up enabling your pre-clinical program.